Cure My Disease

Don't miss your cure!

 Log in / Sign up

Does rehab duration matter? study tests 3 vs 4 weeks for getting people back to work

NCT ID NCT07700017

Knowledge-focused Sponsor: Pensionsversicherungsanstalt Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study looks at people with musculoskeletal conditions (like back or joint problems) who take part in a work-specific rehabilitation program called RehaJET. The goal is to see whether a 3-week or a 4-week program leads to better work ability and job outcomes. Researchers will compare the two groups to find out if the extra week makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multimodal rehabilitation with work-specific training (RehaJET)
What this could lead to
If successful, this could help determine the optimal duration for work-focused rehabilitation programs, potentially improving return-to-work rates for people with musculoskeletal conditions.
What could go wrong
This is an observational study, not a randomized trial, so results may be influenced by patient differences. The findings may not apply to all rehabilitation settings or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

499 people

The number who actually took part.

Started

Jul 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with specific work-related rehabilitation needs

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The study participants are patients undergoing the REHAJET programme * Presence of a disease in the area of the musculoskeletal system * Sufficient motivation to maintain professional participation Exclusion Criteria: * No completion of all work-specific rehabilitation modules * Acute or decompensated disease states with severe functional limitations (i.e. not able to continue with the rehabilitation programme)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Musculoskeletal diseases or conditions are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

musculoskeletal system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Musculoskeletal diseases or conditions

Contacts and locations

Locations

  • Pensionsversicherungsanstalt

    Vienna, 1021, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.